Learn More
Medchemexpress LLC Methyl 4-[(2,5-dihydroxyphenyl)methylamino]benzoate | 140674-76-6 | MFCD01074970 | 99.3% | 273.28 g/mol | C15H15NO4 | 50 MG

Supplier: Medchemexpress LLC HY11771850MG
AG957 (methyl 4-[(2,5-dihydroxyphenyl)methylamino]benzoate) is a research-grade tyrosine kinase inhibitor used to study Bcr/Abl signaling. It inhibits p210Bcr/Abl autokinase with an IC50 of 2.9 μM and is supplied as a high-purity analytical standard for laboratory assays.
- High purity of 99.3% suitable for analytical and biological studies.
- Confirmed biological activity: Bcr/Abl inhibition (IC50 = 2.9 μM).
- Molecular weight 273.28 g/mol and formula C15H15NO4 for accurate mass calculations.
- Multiple pack sizes available, including a 50 mg pack for small-scale experiments.
- Stability: powder stored at -20°C for long-term storage; in solvent storage conditions documented for short-term use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.